Clozapine
Antona J. Wagstaff, Harriet M. Bryson · CNS Drugs · 1995
Cited by 100 works. doi:10.2165/00023210-199504050-00006
Authors
References
- Molecular pathology of schizophrenia: more than one disease process?
- Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
- Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States
- Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
- Verapamil
- The Risks and Benefits of Clozapine versus Chlorpromazine
- Clozapine: neuroleptic-induced EPS and tardive dyskinesia
- Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients
- Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
- Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors